ConductScience.org, home

Paper29166151

Biomarkers and Imaging of Breast Cancer.

Weaver O and 1 other. AJR Am J Roentgenol, 2018. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Biomarkers and Imaging of Breast Cancer. Papers, record 29166151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29166151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biomarkers and Imaging of Breast Cancer.
PubMed
Journal
AJR Am J Roentgenol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
2.18
iCite
Revised in PubMed
2018-11-06
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weaver OOlena
2Leung JWTJessica W T

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Breast NeoplasmsMajor topic
Decision Making
Female
Humans
Precision Medicine

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42491985Breast Ultrasound Texture Features of Family History of Breast Cancer and Contraceptive Use in Nigerian Younger Women.J Med Ultrasound2026https://conductscience.org/library/papers/42491985PubMed
41627724Complementary prognostic value of hotspot-to-centroid distance (NHOCpeak) to SUVpeak in high-grade glioma.Ann Nucl Med2026https://conductscience.org/library/papers/41627724PubMed
41624853PILRA serves as a diagnostic and prognostic biomarker and modulates the tumor immune microenvironment and immunotherapy response in breast cancer.Front Immunol2025https://conductscience.org/library/papers/41624853PubMed
41081182Multiparametric MRI-based radiomics nomogram for noninvasive stratification of HER2 expression status in breast cancer.Quant Imaging Med Surg2025https://conductscience.org/library/papers/41081182PubMed
40994911Early and hereditary breast cancer: advances in risk stratification and imaging approaches.Ther Adv Med Oncol2025https://conductscience.org/library/papers/40994911PubMed
40506872Relationships Between Breast Edema and Axillary Lymph Node Metastasis in Breast Cancer.Diagnostics (Basel)2025https://conductscience.org/library/papers/40506872PubMed
39536277Usage of the National Cancer Institute Cancer Research Data Commons by Researchers: A Scoping Review of the Literature.JCO Clin Cancer Inform2024https://conductscience.org/library/papers/39536277PubMed
39290802DNAJC3-AS1 Is Associated with Proliferation, Metastasis, and Poor Prognosis of Breast Cancer.Dis Markers2021https://conductscience.org/library/papers/39290802PubMed
38787156Investigation of α-Klotho Concentrations in Serum of Cats Affected by Hypertrophic Cardiomyopathy.Vet Sci2024https://conductscience.org/library/papers/38787156PubMed
37958390Impact of Imaging Biomarkers and AI on Breast Cancer Management: A Brief Review.Cancers (Basel)2023https://conductscience.org/library/papers/37958390PubMed
36185265The role and application of small extracellular vesicles in breast cancer.Front Oncol2022https://conductscience.org/library/papers/36185265PubMed
36105423MRI as a biomarker for breast cancer diagnosis and prognosis.BJR Open2022https://conductscience.org/library/papers/36105423PubMed
35771747Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.PLoS One2022https://conductscience.org/library/papers/35771747PubMed
35617993Glandular Tissue Component on Breast Ultrasound in Dense Breasts: A New Imaging Biomarker for Breast Cancer Risk.Korean J Radiol2022https://conductscience.org/library/papers/35617993PubMed
35379339Dynamic contrast-enhanced MRI radiomics nomogram for predicting axillary lymph node metastasis in breast cancer.Cancer Imaging2022https://conductscience.org/library/papers/35379339PubMed
34413267The potential role of abnormal angiotensin-converting enzyme 2 expression correlated with immune infiltration after SARS-CoV-2 infection in the prognosis of breast cancer.Aging (Albany NY)2021https://conductscience.org/library/papers/34413267PubMed
34377307Relationship between ultrasound values and pathology and metastasis in patients with breast cancer.Am J Transl Res2021https://conductscience.org/library/papers/34377307PubMed
34200484Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach.Int J Mol Sci2021https://conductscience.org/library/papers/34200484PubMed
33919342Identification of Tumor-Specific MRI Biomarkers Using Machine Learning (ML).Diagnostics (Basel)2021https://conductscience.org/library/papers/33919342PubMed
33627501Exosomes in Breast Cancer - Mechanisms of Action and Clinical Potential.Mol Cancer Res2021https://conductscience.org/library/papers/33627501PubMed

See all 34 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29166151

GET https://conductscience.org/api/papers/v1/29166151/cited_by?page=2